Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

How mass spectrometry helps identify peptides

Understand the difference between an observed ion, an inferred molecular mass and the additional evidence needed to support a peptide identity.

Mass spectrometry can provide powerful evidence for a peptide's identity, but it does not begin by reading a name off a molecule. The instrument measures ions. Interpreting those signals requires a model of the ion's charge and composition, followed by a comparison with the candidate structure or reference.

The measured quantity is mass-to-charge ratio

A mass spectrometer analyses ions according to mass-to-charge ratio, written m/z. A spectrum shows ion signals at those ratios. The observed ion can differ from the neutral molecule through protonation, loss of a proton or another ion-forming process, so interpreting its position requires knowing what ion is being assigned.Waters MS primer (opens in a new tab)

For an original simplified example, an ion with a mass close to 1,000 mass units and charge magnitude two appears near m/z 500. The example illustrates division by charge; it deliberately omits the small ion-composition adjustments needed for an exact assignment. A peak near 500 is not automatically evidence for a neutral molecule of mass 500.

That is why an identity note should preserve the assigned ion and charge state alongside the reported mass. A number stripped of those labels can appear to disagree with a molecular specification when the two entries are actually describing different quantities.

Compare observed evidence with a defined candidate

First establish the candidate's sequence and chemical form. Then ask which predicted ion or molecular mass was compared with the measurement and what agreement criterion the laboratory applied. A broad product name without terminal or modification detail can leave the candidate insufficiently defined.

Pieces of an interpretable mass-based identity claim
PieceQuestion
CandidateWhich sequence and modifications are being assessed?
Observed signalWhich ion and charge state were assigned?
ComparisonWhich predicted value or reference was used?
AcceptanceWhat tolerance and other criteria governed the conclusion?
LimitationsWhich alternatives could still fit the evidence?

The instrument name alone does not supply those answers. LC-HRMS indicates a technical approach, but a certificate stating that acronym may still provide only a short summary of the underlying identity assessment. Ask for the relevant detail if the project's question needs it.

Fragments can add structural information

Tandem mass spectrometry examines product ions generated from selected precursor ions. The additional pattern can help assess structure beyond the precursor's intact mass. Waters' instrument primer describes the use of fragmentation and successive stages of mass analysis to obtain this extra information.Waters tandem-MS primer (opens in a new tab)

Think of the intact-mass result as one constraint on the candidate and fragment evidence as additional constraints. A candidate consistent with the first observation may fail to explain a diagnostic fragment. Conversely, an incomplete fragment pattern may leave some parts of the candidate unresolved.

Some alternatives remain difficult to distinguish

Leucine and isoleucine illustrate an important boundary: these isomeric residues have the same elemental composition, so replacing one with the other does not create an intact-mass difference. Specialised fragmentation can sometimes distinguish them; Waters demonstrates such assignments using electron capture dissociation and diagnostic product ions in a specific application.Waters ECD application note (opens in a new tab)

Do not generalise that demonstration into a claim that every routine mass measurement distinguishes every residue or stereochemical alternative. The useful question is whether the procedure generated evidence that discriminates the particular alternatives relevant to your sample.

Similarly, an identity assignment does not supply an amount per vial unless a quantitative method and result are also reported. A substance can be detected and assigned without the report establishing how much was present on the basis your project requires.

Write an evidence-based identity note

  • Name the candidate and its structural qualifications.
  • Record the observed ion or reported mass basis.
  • Identify the comparison reference and criteria where provided.
  • State whether fragment or other complementary evidence is available.
  • Keep remaining ambiguities and missing method details explicit.

A useful conclusion describes the evidence supporting the laboratory's assignment. It does not turn mass agreement into an unlimited guarantee. This distinction lets you value the measurement while still asking whether it is sufficient for the research decision at hand.

Sources and further detail

  1. Waters — What is mass spectrometry and how does it work? (opens in a new tab)

    Instrument primer; ion measurement, mass-to-charge ratio and interpretation of spectra.

  2. Waters — Mass spectrometry instruments and tools (opens in a new tab)

    Instrument primer on tandem analysis and fragmentation. Not a specification for an unreported assay.

  3. Waters — Biotherapeutic characterisation using electron capture dissociation (opens in a new tab)

    Application note 720008287, section on leucine/isoleucine, PDF pages 9–11. A specific demonstrated method, not a claim that every LC-MS assay can distinguish these residues.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.